1. Home
  2. SNTI vs PPBT Comparison

SNTI vs PPBT Comparison

Compare SNTI & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNTI
  • PPBT
  • Stock Information
  • Founded
  • SNTI 2016
  • PPBT 2010
  • Country
  • SNTI United States
  • PPBT Israel
  • Employees
  • SNTI N/A
  • PPBT N/A
  • Industry
  • SNTI Biotechnology: Pharmaceutical Preparations
  • PPBT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNTI Health Care
  • PPBT Health Care
  • Exchange
  • SNTI Nasdaq
  • PPBT Nasdaq
  • Market Cap
  • SNTI 19.1M
  • PPBT 8.8M
  • IPO Year
  • SNTI N/A
  • PPBT N/A
  • Fundamental
  • Price
  • SNTI $3.90
  • PPBT $3.78
  • Analyst Decision
  • SNTI Strong Buy
  • PPBT Strong Buy
  • Analyst Count
  • SNTI 1
  • PPBT 2
  • Target Price
  • SNTI $12.00
  • PPBT $126.50
  • AVG Volume (30 Days)
  • SNTI 138.1K
  • PPBT 155.9K
  • Earning Date
  • SNTI 11-14-2024
  • PPBT 11-15-2024
  • Dividend Yield
  • SNTI N/A
  • PPBT N/A
  • EPS Growth
  • SNTI N/A
  • PPBT N/A
  • EPS
  • SNTI N/A
  • PPBT N/A
  • Revenue
  • SNTI N/A
  • PPBT N/A
  • Revenue This Year
  • SNTI $11.52
  • PPBT N/A
  • Revenue Next Year
  • SNTI $78.57
  • PPBT N/A
  • P/E Ratio
  • SNTI N/A
  • PPBT N/A
  • Revenue Growth
  • SNTI N/A
  • PPBT N/A
  • 52 Week Low
  • SNTI $1.52
  • PPBT $2.00
  • 52 Week High
  • SNTI $16.94
  • PPBT $20.60
  • Technical
  • Relative Strength Index (RSI)
  • SNTI 47.20
  • PPBT 46.38
  • Support Level
  • SNTI $3.50
  • PPBT $3.18
  • Resistance Level
  • SNTI $4.77
  • PPBT $5.20
  • Average True Range (ATR)
  • SNTI 0.48
  • PPBT 0.52
  • MACD
  • SNTI -0.08
  • PPBT -0.01
  • Stochastic Oscillator
  • SNTI 25.00
  • PPBT 29.70

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.

Share on Social Networks: